Skip to content
GLP-1 Scorecard
Menu
Site position #314

Meto

Published by GLP-1 ScorecardUpdated

Meto is an insurance-accepting metabolic telehealth platform offering compounded semaglutide and compounded tirzepatide, prescribed after clinician-ordered lab work.

Visit MetoWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
Not disclosed
Tirzepatide
Not disclosed
Coverage
Coverage not published
Brand-name
Not confirmed

Line Meto up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value45/100
Dose & formulation40/100
Clinical oversight88/100
Labs & monitoring85/100
Fulfillment67/100
Contract terms55/100

Strengths

  • Accepts major insurance (Blue Cross, Anthem, United, Aetna) — most patients pay $0–50 per visit
  • Requires lab work before prescribing GLP-1s; addresses root-cause metabolic drivers
  • Matches patients with endocrinologists and obesity medicine specialists within minutes
  • Offers compounded semaglutide and tirzepatide with board-certified physician oversight
  • Handles all prior-auth paperwork; provider location pages exist for all 50 US states

What to consider

  • Medication pricing fully gated behind quiz — no public cash price for sema or tirz
  • Lab panels are a separate out-of-pocket cost ($199–$399) unless covered by insurance
  • No LegitScript certification or named compounding pharmacy found on any public page
  • Company leadership and clinical team not disclosed publicly
  • Self-pay cash pricing exists per site copy but is not published anywhere

Bottom line — Grade C

Best for: Shoppers who want insurance-accepting metabolic telehealth with compounded sema/tirz, lab monitoring, all 50 states.

Site position #314 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Visit Meto

Closest here

The rankings grading nearest Meto — the realistic shortlist.

CLYR Health#310

CLYR publishes dose-specific prices for one-time compounded medication packs, with optional ongoing care sold separately. Its refund and semaglutide shipping descriptions still need clarification.

AMP Health#311

AMP Health offers compounded semaglutide (injectable and oral) from $199/mo and tirzepatide from $309/mo, plus a $79/mo subscription fee.

FitRx#313

FitRx offers brand-name GLP-1s (Ozempic, Wegovy, Zepbound, Mounjaro) with insurance coordination as low as $25/month, plus compounded semaglutide from $151/month without insurance.

Boston Medical Group#315

Boston Medical Group is an established medical group running a 12-week compounded GLP-1 weight-loss program.

Curve#316

Curve (Try Curve LLC) is a telehealth platform offering compounded semaglutide and tirzepatide, prescribed by Beluga Health providers licensed in all 50 states and dispensed by VialsRx, a US 503A compounding pharmacy.

NexLife#317

NexLife is a LegitScript-certified telehealth platform offering compounded semaglutide (from $145/mo) and compounded tirzepatide (from $186/mo).

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Meto's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Meto's site. Not medical advice; see our disclosure.

← Back to the scorecard